Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers
==============================================================================================================================================================

* Tessa Gargett
* Nga T H Truong
* Bryan Gardam
* Wenbo Yu
* Lisa M Ebert
* Amy Johnson
* Erica C F Yeo
* Nicole L Wittwer
* Gonzalo Tapia Rico
* Jesikah Logan
* Purany Sivaloganathan
* Maria Collis
* Andrew Ruszkiewicz
* Michael P Brown